Abstract
Background
Fungal endocarditis (FE) is a “modern” disease that is considered an emerging cause of infective endocarditis (IE). The most frequently identified fungal pathogens are Candida spp., which are responsible for up to two-thirds of all cases; the remaining cases are due to Aspergillus spp., Histoplasma capsulatum or, more rarely, other yeasts and moulds.
Objectives
To describe the prevalence, clinical characteristics and outcome of FE diagnosed in a single tertiary centre and review the literature concerning FE.
Design and setting
An 8-year retrospective review of the case records of patients attending a single Italian University Centre and diagnosed as having definite or probable IE as defined by the modified Duke criteria.
Results
Six patients were identified from 229 episodes of IE: five cases involved a prosthetic valve, and one a native valve of an intravenous drug user. Five cases were caused by Candida spp. (two by C. albicans, one each by C. lusitaniae, C. dubliniensis and C. glabrata) and one by Aspergillus flavus. Three patients were treated by means of surgery plus antifungal therapy; two received antifungal therapy alone. Three patients survived, but only the patient with Aspergillus endocarditis was followed up for a long time.
Conclusions
FE is difficult to diagnose but generally associated with healthcare infections. The optimal treatment is poorly characterised, and international collaborative studies are urgently needed to evaluate newer antifungal agents.
Similar content being viewed by others
References
Ellis M. Fungal endocarditis. J Infect. 1997;35:99–103.
Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endocarditis: evidence in the world literature, 1965–1995. Clin Infect Dis. 2001;32:50–62.
Pierrotti LC, Baddour LM. Fungal endocarditis, 1995–2000. Chest. 2002;122:302–10.
Ferraris L, Milazzo L, Ricaboni D, et al. Profile of infective endocarditis observed from 2003–2010 in a single center in Italy. BMC Infect Dis. 2013;13:545.
Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297:1354–61.
Cicalini S, Puro V, Angeletti C, Chinello P, Macrì G, Petrosillo N. Profile of infective endocarditis in a referral hospital over the last 24 years. J Infect. 2006;52:140–6.
Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.
Lefort A, Chartier L, Sendid B, et al. Diagnosis, management and outcome of Candida endocarditis. Clin Microbiol Infect. 2012;18:e99–109.
Wilson WR, Jaumin PM, Danielson GK, Giuliani ER, Washington JA III, Geraci JE. Prosthetic valve endocarditis. Ann Intern Med. 1975;82:751–6.
Bhatti S, Vilenski L, Tight R, Smego RA Jr. Histoplasma endocarditis: clinical and mycologic features and outcomes. J Infect. 2005;51:2–9.
Steinbach WJ, Perfect JR, Cabell CH, et al. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect. 2005;51:230–47.
Smego RA Jr, Ahmad H. The role of fluconazole in the treatment of Candida endocarditis. A meta-analysis. Medicine. 2011;90:237–49.
Garzoni C, Nobre VA, Garbino J. Candida parapsilosis endocarditis: a comparative review of the literature. Eur J Clin Microbiol Infect Dis. 2007;26:915–26.
Kalokhe AS, Rouphael N, El Chami MF, Workowski KA, Ganesh G, Jacob JT. Aspergillus endocarditis: a review of the literature. Int J Infect Dis. 2010;14:e1040–7.
McCormack J, Pollard J. Aspergillus endocarditis 2003–2009. Med Mycol. 2011;49(Suppl 1):s30–4.
Pasqualotto AC, Denning DW. Post-operative aspergillosis. Clin Microbiol Infect. 2006;12:1060–76.
Melgar GR, Nasser RM, Gordon SM, Lytle BW, Keys TF, Longworth DL. Fungal prosthetic valve endocarditis in 16 patients. An 11-year experience in a tertiary care hospital. Medicine. 1997;76:94–103.
Boland JM, Chung HH, Robberts FJL, et al. Fungal prosthetic valve endocarditis: Mayo clinic experience with a clinicopathological analysis. Mycoses. 2010;54:354–60.
Benjamin DK, Mirò JM, Hoen B, et al. Candida endocarditis: contemporary cases from the International Collaboration of Infectious Endocarditis merged database (ICE-MD). Scand J Infect Dis. 2004;36:453–5.
Baddley JW, Benjamin DK, Patel M, et al. Candida infective endocarditis. Eur J Clin Microbiol Infect Dis. 2008;27:519–29.
Falcone M, Barzaghi N, Carosi GP, et al. Candida infective endocarditis. Report of 15 cases from a prospective multicenter study. Medicine. 2009;88:160–8.
Cobo M, Ramos A, Toquero J, et al. Aspergillus infection of implantable cardioverter–defibrillators and pacemakers: case report and literature review. Eur J Clin Microbiol Infect Dis. 2007;26:357–61.
Halawa A, Henry PD, Sarubbi FA. Candida endocarditis associated with cardiac rhythm management devices: review with current treatment guidelines. Mycoses. 2010;54:e168–74.
Riviere S, Lortholary O, Michon J, et al. Aspergillus endocarditis in the era of new antifungals: major role for antigen detection. J Infect. 2013;67:85–8.
LaBarbera M, Jacobson LB. Invasive aspergillosis in an immunocompetent patient with fever and cardiac mass. Infect Dis Rep. 2011;3:e12.
Nose K, Nishioka T, Hayashi T. Infective endocarditis due to Aspergillus following kidney transplantation. Int J Urol. 2011;18:801–2.
Palomares JC, Bernal S, Marin M, et al. Molecular diagnosis of Aspergillus fumigatus endocarditis. Diagn Microbiol Infect Dis. 2011;70:534–7.
Lazaro M, Ramos A, Ussetti P, et al. Aspergillus endocarditis in lung transplant recipients: case report and literature review. Transpl Infect Dis. 2011;13:186–91.
Jensen J, Guinea J, Torres-Narbona M, Munoz P, Pelaez T, Bouza E. Post-surgical invasive aspergillosis: an uncommon and under-appreciated entity. J Infect. 2010;60:162–7.
Philippe B, Grenet D, Honderlick P, et al. Severe Aspergillus endocarditis in a lung transplant recipient with a five-year survival. Transpl Infect Dis. 2010;12:273–6.
Badiee P, Alborzi A, Shakiba E, Ziyaeyan M, Pourabbas B. Molecular diagnosis of Aspergillus endocarditis after cardiac surgery. J Med Microbiol. 2009;58:192–5.
Morio F, Treilhaud M, Lepelletier D, et al. Aspergillus fumigatus endocarditis of the mitral valve in a heart transplant recipient: a case report. Diagn Microbiol Infect Dis. 2008;62:453–6.
Peman J, Ortiz R, Osseyran F, et al. Native valve Aspergillus fumigatus endocarditis with blood culture positive and negative for galactomannan antigen. Case report and literature review. Rev Iberoam Micol. 2007;24:157–60.
Saitoh T, Matsushima T, Matsuo A, et al. Small-bowel perforation accompanied by Aspergillus endocarditis in a patient with angioimmunoblastic T-cell lymphoma. Ann Hematol. 2007;86:71–3.
McCracken D, Barnes R, Poynton C, White PL, Isik N, Cook D. Polymerase chain reaction aids in the diagnosis of an unusual case of Aspergillus niger endocarditis in a patient with acute myeloid leukaemia. J Infect. 2003;47:344–7.
Lopez J, Revilla A, Vilacosta I, et al. Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis. Eur Heart J. 2007;28:760–5.
Fernandez Guerrero ML, Alvarez B, Manzarbeitia F, Renedo G. Infective endocarditis at autopsy. A review of pathologic manifestations and clinical correlates. Medicine. 2012;91:152–64.
Thuny F, Fournier P-E, Casalta J-P, et al. Investigation of blood culture-negative early prosthetic valve endocarditis reveals high prevalence of fungi. Heart. 2010;96:743–7.
Grijalva M, Horvath R, Dendis M, et al. Molecular diagnosis of culture negative infective endocarditis: clinical validation in a group of surgically treated patients. Heart. 2003;89:263–8.
Antinori S. Histoplasma capsulatum: more widespread than previously thought. Am J Trop Med Hyg. 2014;90:982-3.
Sun X-L, Zhang J, Wang G–G, et al. Comparison of characteristics and short-term outcome from fungal infective endocarditis in prosthetic valve endocarditis versus native valve endocarditis. Am J Cardiol. 2013;112:111–6.
Carr MJ, Clarke S, O’Connell F, Sullivan DJ, Coleman DC, O’Connell B. First reported case of endocarditis caused by Candida dubliniensis. J Clin Microbiol. 2005;43:3023–6.
Tran C, Cometta A, Letovanec I, et al. Candida dubliniensis in recurrent polymicrobial tricuspid endocarditis. Echocardiography. 2007;24:756–9.
Garcia J, Soch K, Matthew E, Surani S, Horseman MA. Endocarditis caused by Candida dubliniensis. Am J Med Sci. 2013;346:237–9.
Wendt B, Hagland L, Razavi A, Rath R. Candida lusitaniae, an uncommon cause of prosthetic valve endocarditis. Clin Infect Dis. 1998;26:769–70.
Michel RG, Kinasewitz GT, Drevets DA, Levin JH, Warden WD. Prosthetic valve endocarditis caused by Candida lusitaniae, an uncommon pathogen: a case report. J Med Case Rep. 2009;3:7611.
Ells R, Kock JLF, Pohl CH. Candida albicans or Candida dubliniensis? Mycoses. 2009;54:1–16.
Khan Z, Ahmad S, Joseph L, Chandy R. Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen. PLoS One. 2012;7:e32952.
Pappas PG, Kaufmann CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503–35.
Cornerly OA, Bassetti M, Calandra T, et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012;18(Suppl. 7):19–37.
Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009). The task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of cardiology. Eur Heart J. 2009;19:2369–413.
Gardiner BJ, Slavin MA, Korman TM, Stuart RL. Hampered by historical paradigms – echinocandins and the treatment of Candida endocarditis. Mycoses 2014;57:316–9.
Kuhn DM, George T, Chandra J, et al. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother. 2002;46:1773–80.
Rubinstein E, Noriega ER, Simberkoff MS, et al. Tissue penetration of amphotericin B in Candida endocarditis. Chest. 1974;66:376–7.
Acknowledgments
The authors wish to thank Mrs. Enza Pallone for carefully selecting for the patients’ records from the in-hospital database, Dr. Alessandro Cialfi for his valuable contribution regarding echocardiography, Prof. Carlo Antona for his cardiosurgery contribution and Dr Giuliano Rizzardini for his helpful advice.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Antinori, S., Ferraris, L., Orlando, G. et al. Fungal Endocarditis Observed Over an 8-Year Period and a Review of the Literature. Mycopathologia 178, 37–51 (2014). https://doi.org/10.1007/s11046-014-9754-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-014-9754-4